Prior to commencing each interview, informed consent was obtained from each participant.
There is evidence today to show that while individuals needing HCV treatment often report not having enough information about both its associated risks and benefits [ 17], they tend to show much greater interest in commencing treatment once informed [ 56].
Before the study commenced, all respondents were informed of the confidentiality and anonymity of the collected data, as well as how it would be represented.
Before the study commenced, everyone involved was informed in writing and orally about the aim of the study, that participation was voluntary and that confidentiality would be maintained.
Before commencing, participants were informed that their answers would be anonymised and treated with strict confidentiality.
Before the experiments commenced the participants had been informed that they would never be stabbed with the needle and that they would not experience any painful stimulation (see below).
The moderator (CI) commenced the interview sessions by informing about the study's purpose, limits of confidentiality, and their right to withdraw according to the Helsinki Declaration.
Thirty children were lost to follow-up between obtaining informed consent and commencing the study; therefore, the 298 children who began the study serve as the study cohort.
Individual blood pressure measurement commenced after the person had given informed consent, the inclusion criteria were satisfied, and personal information was obtained.
Patients were extensively informed prior to commencing therapy and provided written informed consent concerning the use of their data for research purposes.
